Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
-
Shares outstanding
-
9,036,176
-
Total 13F shares
-
21,663,295
-
Share change
-
-423,009
-
Total reported value
-
$60,814,324
-
Price per share
-
$2.81
-
Number of holders
-
32
-
Value change
-
-$819,632
-
Number of buys
-
10
-
Number of sells
-
26
Institutional Holders of Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) as of Q1 2023
As of 31 Mar 2023,
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,663,295 shares.
The largest 10 holders included
Kynam Capital Management, LP, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, FIL Ltd, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BARCLAYS PLC, RENAISSANCE TECHNOLOGIES LLC, and BANK OF AMERICA CORP /DE/.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.